RAIN - Rain Enhancement Technologies Holdco, Inc. Class A Common Stock
Rain Enhancement Technologies Holdco, Inc. Class A Common Stock Logo

RAIN - Rain Enhancement Technologies Holdco, Inc. Class A Common Stock

https://rainwatertech.com
Momentum: Bearish
Recent News
Powered by Alpha Vantage

No recent news found.

AI Tools
Key Metrics
Trend: Downtrend
Source: Snapshot

Rain Therapeutics Inc., a clinical-stage precision oncology company, is dedicated to developing therapies that target oncogenic drivers in the United States. The company is headquartered in Newark, California.

52W High
$10.84
52W Low
$1.75
MA Status:
50D: Below 200D: Below
Beta (~1 neutral, <0.9 lower risk)
-0.22
Valuation
As of 2025-03-31 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
N/A
EV/Revenue (<3 favorable)
N/A
P/S (TTM) (<3 favorable)
N/A
P/B (<3 favorable)
N/A
Ownership
Retail‑heavy
Source: Overview
Insiders (1–5% typical)
71.60%
Institutions (25–75% balanced)
11.89%
Shares Outstanding
7,528,800
Float
1,882,800
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
As of 2025-03-31 (Overview)
Revenue (TTM)
0
Gross Profit (TTM)
0
EPS (TTM)
-0.79
Profit Margin (>10% good)
N/A
Operating Margin (TTM) (higher better)
N/A
ROE (TTM) (>15% strong)
N/A
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
N/A
Momentum
Bearish momentum
Value
0.8493
Previous
0.8038
Trend
Rising
Signal Cross
No cross
As of
Sep. 12, 2025